Wird geladen...
Bioequivalence of perampanel fine granules and tablets in healthy Japanese subjects
Objective: Perampanel is an approved anti-seizure drug. A new formulation of perampanel fine granules (FG; 1% perampanel) has been developed for patients who are unable to take tablets. Bioequivalence between the 4-mg FG and tablet perampanel formulations, as well as their safety and tolerability, w...
Gespeichert in:
| Veröffentlicht in: | Int J Clin Pharmacol Ther |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Dustri-Verlag Dr. Karl Feistle
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7659282/ https://ncbi.nlm.nih.gov/pubmed/32870153 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5414/CP203781 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|